Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PRVA · against 1,372 other Healthcare companies
Ranked #691 of 1,373 · scores higher than 50% of peers · safety percentile 50
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)137 peers with a safety percentile of 40–49, including PRVA · Click a bar to see the companies
A mix: stronger debt / equity, but weaker beta and current ratio than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | PRVA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 0.01× | 0.24× | 89% | 33% | |
| BetaLower is better · 1,320 reported | 0.88 | 0.53 | 30% | 33% | |
| Current ratioHigher is better · 1,338 reported | 1.62× | 2.62× | 30% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 687 | 12.2B CNY (≈$1.7B) | 50 | 39 | |
| 688 | 27.5B NZD (≈$16.5B) | 50 | 69 | |
| 689 | 14.3B TRY (≈$428M) | 50 | 60 | |
| 690 | 93.7B KRW (≈$67M) | 50 | 36 | |
| 691 | 2.7B USD | 50 | 56 | |
| 692 | 3.01T KRW (≈$2.2B) | 50 | 53 | |
| 693 | 423.1B JPY (≈$2.9B) | 50 | 65 | |
| 694 | 528M USD | 49 | 58 | |
| 695 | 363.6B KRW (≈$262M) | 49 | 55 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score